🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiulong Shen

Io Therapeutics (United States)

ORCID: 0000-0003-2988-5423

NeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Progress towards drug discovery for Friedreich’s Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein”.

Progress towards drug discovery for Friedreich’s Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein

Bioorganic & Medicinal Chemistry(2020)10.1016/j.bmc.2020.115472

N/A

0DataRank · unranked

17 citations

Johnathan Wong, Thahza P. Prakash, Frank Rigo, Yanjie Li, Марек Напиерала +2 more

Targeting 3′ and 5′ untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression

Nucleic Acids Research(2021)10.1093/nar/gkab954

N/A

0DataRank · unranked

26 citations

Jixue Li, Jun Wang, David R. Lynch, Xiulong Shen, David R. Corey +7 more

Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice

RNA Biology(2022)10.1080/15476286.2022.2043650

N/A

0DataRank · unranked

7 citations

Jun Wang, Xiulong Shen, Frank Rigo, Thahza P. Prakash, Марек Напиерала +2 more